Bayer Balance Sheet Health
Financial Health criteria checks 2/6
Bayer has a total shareholder equity of €30.7B and total debt of €41.2B, which brings its debt-to-equity ratio to 134.1%. Its total assets and total liabilities are €106.9B and €76.3B respectively. Bayer's EBIT is €9.2B making its interest coverage ratio 11.3. It has cash and short-term investments of €6.3B.
Key information
134.1%
Debt to equity ratio
€41.16b
Debt
| Interest coverage ratio | 11.3x |
| Cash | €6.34b |
| Equity | €30.69b |
| Total liabilities | €76.25b |
| Total assets | €106.95b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BAYA's short term assets (€33.1B) exceed its short term liabilities (€25.0B).
Long Term Liabilities: BAYA's short term assets (€33.1B) do not cover its long term liabilities (€51.2B).
Debt to Equity History and Analysis
Debt Level: BAYA's net debt to equity ratio (113.5%) is considered high.
Reducing Debt: BAYA's debt to equity ratio has increased from 92.1% to 134.1% over the past 5 years.
Debt Coverage: BAYA's debt is not well covered by operating cash flow (19.4%).
Interest Coverage: BAYA's interest payments on its debt are well covered by EBIT (11.3x coverage).